INTRODUCTION
Lipidomics has been defined as the full characterization of lipid molecular species and of their biological roles with respect to expression of proteins involved in lipid metabolism and function, including gene regulation (1) . It has evolved as a separate discipline within the field of metabonomics since lipids have extraordinary structural diversity and play such important roles in the pathophysiology of diseases (2, 3) . Metabonomics, which is often used interchangeably with the term of metabolomics, provides a quantitative measurement of the multivariate metabolic responses of multicellular systems to pathophysiological stimuli or genetic manipulations (4) . Now systems biology and functional genomics are trying to integrate metabonomic and lipidomic information with genomic, proteomic and transcriptomic information to improve our understanding of mechanisms for human disease (5, 6) . The rapid growth of lipidomics has primarily resulted from technological advances in mass spectrometry (MS). Gas chromatography (GC)-MS coupled with electron capture negative chemical ionization (ECNCI) was traditionally used for lipid analyses. Subsequently, the range of lipids that could be analyzed by MS was significantly expanded by discoveries of electrospray ionization (ESI) (7) , atmospheric pressure chemical ionization (APCI) (8) and ECAPCI (9) . Furthermore, by coupling liquid chromatography (LC) to MS, it has become possible to greatly increase the number of lipids that can be analyzed in a single experiment. Finally, the use of tandem mass spectrometry (MS/MS) can provide the detailed structural information necessary for characterization of novel lipids and the selectivity required for the determination of individual lipid species present in complex mixtures. Therefore, MS-based lipidomics methodology has become an essential tool for monitoring global differences in cellular lipid metabolism (2, 3) . Such studies can also provide quantitative information on precursors to important bioactive lipids that play key roles in cellular functions (Scheme 1). However, the bioactive lipids themselves are present in only trace quantities and cannot be detected by global analyses. Analysis of trace amounts of bioactive lipids is further complicated by their physicochemical properties. Many of them bind to active sites on glassware and chromatography equipment, which results in specific losses of particular lipids. Fortunately, the use of stable isotope internal standards coupled with MS detection can prevent this problem because the stable isotopes act as carriers through complex work up and analysis procedures. This has led to the development of targeted approaches, which provide more detailed information than global analyses. However, the precision and accuracy of the data compensates for the more limited analytical targets. http://bmbreports.org 
Targeted chiral lipidomics by LC-ECAPCI/MS
Under conventional APCI conditions, the high-energy electrons from the corona discharge collide with the nitrogen sheath gas to form the N2
•＋ radical cations that initiate the ionization process (10) . We reasoned that the low-energy electrons generated in the APCI source could also ionize suitable electron capturing molecules such as pentafluorobenzyl (PFB)-ester derivatives, through dissociative electron capture procedure (Fig.  1 ). The ionization process would then be analogous to ECNCI during GC-MS analysis (11) . The initially formed radical anion would dissociate into a PFB radical and a carboxylate anion (Fig. 1) . We discovered that ECAPCI indeed occurred in the APCI source and that ultrahigh sensitivity was obtained by analyzing the carboxylate anions derived from PFB ester derivatives of non-esterified oxidized lipids (9) . Usually, a 25-100 fold increase in sensitivity for oxidized lipids is achieved by ECAPCI/MS compared with conventional APCI methods (9) . When 15(S)-hydroxyeicosatetraenoic acid (HETE)-PFB was analyzed under negative APCI conditions, an intense negative ion was observed at m/z 319, due to dissociation of a PFB radical from the initially formed radical anion, [M] •− ( Fig. 2A) (3, 9) . If conventional APCI had occurred, a negative ion corresponding to [M-H] would have been observed at m/z 499. In fact, when 15(S)-HETE-PFB was analyzed by positive APCI, the expected protonated molecule [MH] ＋ was observed at m/z 501. This meant that dissociative EC, a novel ionization process, had occurred in the source of the mass spectrometer under negative APCI conditions ( Fig. 2A) . We named the technique, ECAPCI (9) . Importantly, the structural integrity of the thermally labile HETE was maintained during the EC process, which suggested that this technique would be useful for highly specific and sensitive analyses. Additional analytical specificity was conferred by the use of collision-induced dissociation (CID). Thus, CID of m/z 319, the [M-PFB] -ion for 15-HETE, resulted in the formation of product ion at m/z 219 that was diagnostic for 15-HETE through an α-hydroxy cleavage of the C-14 and C-15 bond at the vinylic position (Fig. 2B) . This made ]-15(S)-HETE used as the internal standard. Similar types of specific transitions were observed for many of the other oxidized lipids derived from arachidonic acid (AA) and linoleic acid (LA) (3, 12) . The resolution of enantiomeric forms of bioactive lipids is required in order to distinguish enzymatically generated lipids from those arising non-enzymatically through the action of reactive oxygen species (ROS). Typically, resolution of enantiomeric bioactive lipids has been conducted using normal phase chiral chromatography. In order to utilize the power of stable isotope labeled internal standards, it is necessary to use MS as the detection system. Unfortunately, both ESI and APCI have quite limited sensitivity for analyzing non-esterified bioactive lipids when normal-phase solvents are employed. In contrast, LC-ECAPCI/MS analyses of oxidized lipids PFB-derivatives can be conducted using normal phase solvents and chiral columns without loss of sensitivity. This makes it possible to separate complex mixtures of AA-and LA-derived lipid enantiomers and to quantify them with very high sensitivity using stable isotope dilution methodology (3, (12) (13) (14) . http://bmbreports.org Chiral LC was conducted with isopropanol/methanol/hexane as a solvent system (Fig. 3) . This was used in combination with LC-ECAPCI/MRM/MS for analysis of PFB-ester derivatives of 25 lipids and 12 heavy isotope analogue internal standards. It was possible to separate all the regioisomers and enantiomers by this technique. The PFB-esters of 9-HODE and 13-HODE were distinguished by the product ions at m/z 171 and 195, respectively (Fig. 3A) ; whereas, 5-, 8-, 11-, 12-and 15-HETE were distinguished by specific product ions at m/z 115, 155, 167, 179 and 219, respectively (Fig. 3B) . The R-enantiomers generally eluted ahead of the S-enantiomers. The isomeric prostaglandin (PG) derivatives such as PGD2 and PGE2 as well as PG and isoprostane (iP) isomers such as PGF2α and iPF2α-III, respectively were also resolved under these conditions (Fig.  3C ). Quantitation was performed by use of 12 heavy isotope internal standards. Detection limits for individual eicosanoids were found to be in the fg range.
Bioactive eicosanoid lipids
Arachidonic acid (AA) is an important fatty acyl component of the lipidome. It is found esterified in sterol lipids and at the sn-2 position of glycerolipids and glycerophospholipids (especially phosphatidylethanolamine, phosphatidylcholine and phosphatidylinositides) of cell membranes of the body and brain (15) . AA is released by lipases such as a cytosolic phospholipase A2 (cPLA2, 85 kDa) and a low-molecular-weight secretory PLA2 (sPLA2, 14-18 kDa) (16) . AA is oxidized to various bioactive lipophilic compounds called eicosanoids, including PGs, thromboxanes (TXs), leukotrienes (LTs), lipoxins, epoxides and alcohols such as HETEs (17) . Many of the eicosanoids are potent lipid mediators of inflammation, asthma, fever, pain, hypertension, stroke and other pathologies (18) . For example, cyclooxygenase (COX)-derived eicosanoids such as PGs and TXs have important roles as autacoids involved in the regulation of cardiovascular function (19) and tumor progression (20) . In contrast, lipoxygenase (LO)-derived eicosanoids such as LTs have been implicated as important mediators of inflammation, asthma, cardiovascular disease and cancer (21) . Cytochrome P-450 (P450)-derived epoxyeicosatrienoic acids (EETs) and their hydration products, the dihydroxyeicosatrienoic acids (DHETs), are vasodilators (22) , whereas P450-derived 20-HETE is a vasoconstrictor (23) . Some ROS-derived iPs have been implicated as mediators of vasoconstriction in different vascular beds (24) . However, the intense interest in iPs stems primarily from their utility as biomarkers of oxidative stress (25) . AA-derived hydroperoxides (HPETEs; hydroperoxyeicosatetraenoic acids) are formed enzymatically or non-enzymatically. HPETEs formed on esterified lipids are reduced to the corresponding HETEs by peroxiredoxin VI (26) or phospholipid hydroperoxide glutathione (GSH) peroxidase (27) . They are subsequently released by lipases as the corresponding free HETEs (28) . HPETEs formed from free AA are reduced to HETEs by GSH transferases and peroxidases (27, 28) . The resulting free HETEs can then be converted to oxo-eicosatetraenoic acids (oxo-ETEs), which form GSH-adducts (29) . Alternatively, esterified and free HPETEs undergo homolytic decomposition to highly reactive bifunctional electrophiles such as 4-oxo-2(E)-nonenal (ONE) and 4-hydroxy-2(E)-nonenal, which damage cellular DNA (30) (31) (32) , RNA (33), proteins and peptides (34, 35) . ROS initiates a non-enzymatic HPETE formation by abstracting a bis-allylic hydrogen atom (36) . Rearrangement of the resulting allylic radical and non-stereoselective addition of molecular oxygen result in the formation of 24 different HPETE isomers when AA was used as a substrate. In contrast, COXand LO-mediated HPETE formation is highly stereoselective. For example, COX-2 converts AA to 11(R)-, 15(S)-and 15(R)-HPETE (29), whereas 15-LO-1 converts AA to 12(S)-and 15(S)-HPETE (17) . A targeted chiral lipidomics approach has been successfully employed to analyze eicosanoid enantiomers and diastereomers with high sensitivity and specificity and elucidate the roles of eicosanoids in various cellular systems, which are detailed in the following sections.
COX-2-mediated metabolism of AA in rat intestinal epithelial cells
COX-mediated pathways of AA metabolism have been implicated as important mediators of carcinogenesis (37) . It has been suggested that COX-2 is involved in cellular proliferation, angiogenesis, resistance to apoptosis and modulation of immunosuppression (38) . These biological activities are thought to result primarily through the formation of PGs such as PGE2. However, little attention has been given to the potential for the formation of genotoxic bifunctional electrophile such as ONE (39, 40) , which arises from homolytic decomposition of COX-2-derived lipid hydroperoxides (30, 41) . ONE can covalently modify DNA bases (42) (43) (44) . We reasoned that using rat intestinal epithelial cells permanently expressing COX-2 gene (RIES cells), it would be possible to determine the major lipid hydroperoxide that is responsible for covalent modifications to cellular DNA. Furthermore, it would be possible to examine the effects of aspirin (a non-specific COX inhibitor) on lipid production and DNA modification. RIES cells were grown to confluence and incubated for a further 24-h in media containing 0.1% FBS. Most of the serum was removed because of the potential interference in LC-MS assays from endogenous eicosanoids that are present. Serumfree media was separated from cells at the end of the incubation. Lipids and their heavy isotope internal standards were extracted from the media and converted to PFB derivatives, which were then subjected to a targeted chiral lipidomics analysis. Intact RIES cells were shown to produce 15(S)-HETE together with PGE2 ( Fig. 4A) (30) . Quantitatively, there was approximately two times as much PGE2 secreted as 15(S)-HETE. This implied that the major lipid hydroperoxide was 15(S)-HPETE, which undergoes homolytic decomposition to ONE, a precursor of heptanone-etheno-2'-deoxyguanosine (HεdGuo). How-http://bmbreports.org BMB reports ever (as described below) in a subsequent study, we showed that 11(R)-HPETE was initially the most abundant of the COX-2-derived HPETEs formed through metabolism of exogenously added AA (29) , suggesting that it could make a major contribution to the formation of the etheno adducts that were identified in the DNA of RIES cells. The selective COX-2 inhibitor NS-398 was protective against cellular DNA damage. Biosyntheses of endogenously-derived PGE2 and 15(S)-HETE were completely inhibited by 110 μM NS-398 ( Fig. 4B ) (30) . PGE2, 15(S)-HETE, 15(R)-HETE and 11(R)-HETE derived from exogenous AA were also inhibited by NS-398 (29) . These studies suggest a potential mechanism of tumorigenesis, which involves DNA-adduct formation from COX-2-mediated lipid peroxidation rather than PG formation. It has been reported previously that aspirin can convert the COX-2 into a 15(R)-LO in vitro. Therefore, it was of interest to determine whether this could occur in the RIES cells, particularly in view of the potential for 15(R)-HPETE to undergo homolytic decomposition to the same genotoxins as the 15(S)-enantiomer. Aspirin at 200 μM completely inhibited the production of 15(S)-HETE and PGE2 (30) . There was a concomitant increase in the formation of 15(R)-HETE as predicted by a previous in vitro study (45) . This suggests that aspirin could in fact potentiate DNA damage through increased formation of 15(R)-HPETE, the precursor of 15(R)-HETE. However, the reduced PGG2 formation in the presence of aspirin would allow the COX-2 peroxidase activity to exclusively reduce the 15(R)-HPETE to 15(R)-HETE. This means that reducing equivalents would not be depleted so readily as in the absence of aspirin. Alternatively, aspirin has antioxidant properties (such as by increasing the peroxidase activity of COX-2) that might rapidly reduce the amount of 15(R)-HPETE that is formed.
Previous studies of COX-2 mediated AA metabolism have been conducted primarily with recombinant enzymes (46) or in cells where the enzyme activity is extremely high (47) . There had been no comprehensive studies of cellular COX-2-mediated AA metabolism. Therefore, a full characterization of eicosanoid biosynthesis was undertaken in the RIES cells in view of the potential for further metabolism of HPETEs and HETEs to bioactive molecules. We reasoned that this would provide a more complete picture of the role that COX-2-mediated AA metabolism plays in tumorigenesis.
When intact RIES cells were treated with calcium ionophore A-23187 (CI, 1 μM) for 1-h, 11(R)-HETE was the most abundant metabolite, followed by PGE2, 15(S)-HETE and 15-oxo-ETE (29) . The ratio of PGE2 to 15(S)-HETE (2.9:1) was similar to that observed in unstimulated cells (1.9:1) after a 24-h incubation. Incubation for a further 23-h after the CI was removed resulted in a substantial increase in PGE2 concentrations while HETEs and 15-oxo-ETE concentrations decreased to almost undetec- 
5-LO-mediated metabolism of AA in human lymphoblastoid CESS cells
5-LO metabolizes AA into 5(S)-HPETE which is either reduced to 5(S)-HETE or serves as a precursor to the formation of leukotrienes (LTs) (Scheme 1) (48). The conversion of AA to 5(S)-HPETE by 5-LO is critically dependent upon the presence of FLAP, the 5-LO-activating protein (49). 5-LO-mediated LT formation is thought to play a critical role in inflammation and allergic disorders (50) since 5-LO and FLAP are expressed primarily in inflammatory cells (48) . In addition, 5-LO-derived AA metabolites LTC4 and LTD4 have been implicated as mediators of atherogenesis and heart disease (Scheme 1) (48). Our previous in vitro studies characterized ONE as one of major products arising from the homolytic decomposition of 5-LO-derived 5(S)-HPETE (31). Cellular 5-LO synthesizes lipid hydroperoxides on the nuclear membrane like COX-2. Therefore, it was highly possible that 5-LO could also mediate the formation of lipid hydroperoxide-derived endogenous DNA-adducts in cells. CESS cells, a human lymphoblastic cell line expressing both 5-LO and FLAP, was employed to elucidate the relationship of 5-LO mediated-lipid peroxidation and DNA-adduct formation. Targeted chiral lipidomics methodology was used to monitor the concomitant formation of lipid hydroperoxides in the presence of different enzyme stimulator or inhibitors.
Western blot analyses revealed that the lymphoblastoid CESS cell line constitutively express both 5-LO and COX-1 ( Fig. 5 ) (51). There was a substantial and stereoselective formation of 5(S)-HETE and LTB4 upon stimulation with CI, which confirmed the presence of a functional 5-LO activity (Fig. 6) . Interestingly, almost equimolar amounts of 5(S)-HETE and LTB4 were generated. This suggested that sufficient 5(S)-HETE could have http://bmbreports.org BMB reports been generated to undergo homolytic decomposition to ONE. MK886, a FLAP inhibitor, inhibited 97% of 5(S)-HETE production and 99% of LTB4 production. Low levels of PGs together with 11(R)-, 15(S)-and 15(R)-HETE were formed by COX-1 expressed in the CESS cells. With aspirin treatment, 11-and 15-HETEs productions were reduced and became racemic (51) . HεdGuo was quantified in the CESS cell DNA. CI stimulation of the CESS cells resulted in a 3-fold increase in HεdGuo over basal levels. MK886 decreased the production of HεdGuo by almost 90% to a level that was not significantly different from the basal levels. In addition, aspirin had no detectable effect on HεdGuo formation. This confirmed that HεdGuo formation in CESS cell DNA arose primarily from 5-LO-mediated lipid peroxidation (51) . Therefore, this novel finding provided additional insight into previous observations that increased 5-LO activity is associated with cancers and cardiovascular diseases (52, 53) .
15-LO-1-mediated metabolism of AA in human monocytes and mouse RAW macrophages
15-LOs can convert both free and esterified AA (54) to HPETEs in contrast to 5-LOs, which strongly prefer free AA as substrate (51 (62) . 15-oxo-ETE was rapidly cleared from the R15L cells, with a half-life of only 11 min, indicating that it underwent further metabolism. As suggested in our previous study (29) , 15-oxo-ETE is also metabolized in the R15L cells to a 15-OEG, which is then hydrolyzed by GGT to a 15-OEC. 15-oxo-ETE was also shown to inhibit the proliferation of human vascular vein endothelial cells (HUVECs) by suppressing DNA synthesis. Thus, in the absence of 15-PGDH, as is found in human colon cancer (63) , no 15-oxo-ETE would be formed and the anti-angiogenesis activity on ECs would be lost. This could then lead to increased tumor growth and metastasis. Therefore, these studies provide a pharmacological basis for the design of new targeted therapeutic strategies to inhibit angiogenesis.
Summary and future perspectives
The high sensitivity and specificity of targeted chiral lipidomics approach using ECAPCI/MS has proved to be particularly useful in our studies on AA metabolism in various cellular systems. We were able to show the importance of endogenous 15(S)-HPETE formation in unstimulated RIES cells as reflected by 15(S)-HETE concentrations (31) . The HεdGuo DNA-adduct found in the DNA of unstimulated RIES cells was shown originally to arise from COX-2-mediated AA metabolism to 15(S)-HPETE (31). However, subsequent studies have suggested that COX-2-mediated AA metabolism to 11(R)-HPETE could also make a significant contribution to HεdGuo DNA-adduct formation in the RIES cells (29) . In contrast, 5-LO-mediated formation of 5(S)-HPETE was responsible for the generation of HεdGuo DNA-adduct in human lymphoblastoid CESS cells (51) . 15-Oxo-ETE was found to be a COX-2-derived metabolite in RIES cells (29) . More recently, it was also found to be a major AA-derived 15-LO-1 metabolite in human monocytes. It arose from 15-PGDH-mediated metabolism of 15(S)-HETE in the human monocytes and was shown to inhibit EC proliferation (59) . The isomeric 5-LO-derived 5-oxo-ETE arises through an analogous pathway involving 5(S)-hydroxyeicosanoid dehydrogenase (5-HEDH). It is a potent chemoattractant for eosinophils and has similar effects on neutrophils, basophils and monocytes (64) . It promotes the survival of tumor cells and blocks the induction of apoptosis by 5-LO inhibitors through activation of the Gi/o-coupled OXE receptor (64) . Further metabolism of 5-oxo-ETE and 15-oxo-ETE results in the formation of GSH-adducts (FOG7 and 15-OEG) and their GGTP-derived cysteinylglycine metabolites that could potentially also have important pharmacological effects in vivo, analogous to the more widely studied sulfidopeptide LTs-LTC4 and LTD4 (Scheme 1). Using LC-ECAPCI/MRM/MS procedures and stable isotope dilution it is now possible to quantify up to 60 eicosanoids in a single analytical run. However, recent developments in LC-MS instrumentation provide even more improved sensitivity and increased number of MRM transitions that can be monitored. It is anticipated that in the future it will be able to extend the current targeted chiral lipidomics methodology to the analysis of P450 metabolites -EETs and DHETs. In addition, this methodology can be readily modified to include oxidized lipids derived from polyunsaturated fatty acids (PUFAs) other than AA and LA such as eicosapentaenoic acid and docosahexaenoic acid. The ability to quantify hundreds of bioactive lipids including eicosanoids in a single analysis would provide an excellent screening tool that helps to further define their roles in diverse pathophysiological processes.
